文献速递脊柱关节炎

关节与皮肤改善对银屑病关节炎患者健康相关生活质量的贡献

The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies.
PubMed 文献 · Ann Rheum Dis · 2019-05-21

该研究为SPIRIT-P1和SPIRIT-P2两项随机对照试验的事后分析,纳入402例基线银屑病皮损面积≥3%体表面积的银屑病关节炎患者,采用响应面模型分析第24周DAPSA与PASI改善对HRQoL的贡献。结果显示EQ-5D VAS的最大改善与DAPSA和PASI同时最大幅度改善相关,而非单一指标改善;SF-36和WPAI各域也呈类似趋势。

要点

  • 关节与皮肤同时改善对HRQoL的贡献优于单一改善。
  • 第24周EQ-5D VAS最大改善与DAPSA和PASI共同最大改善相关。
  • SF-36与WPAI域亦观察到类似模式。

核心结论

  • 银屑病关节炎患者HRQoL的最佳改善依赖于关节和皮肤症状同时得到有效治疗。

研究设计与样本

  • SPIRIT-P1和SPIRIT-P2两项3期随机对照试验的事后分析,评估ixekizumab(IL-17A拮抗剂)治疗活动性PsA。
  • 整合分析纳入402例基线银屑病皮损面积≥3%体表面积的PsA患者。
  • 采用平滑样条法和响应面图形建模关节与皮肤改善对HRQoL的贡献。

主要发现

  • 第24周EQ-5D VAS最大改善与DAPSA和PASI同时最大幅度改善相关,而非DAPSA或PASI单独改善。
  • SF-36各域和WPAI也观察到类似结果。

关键数值与推荐

  • 评估指标包括DAPSA、PASI、EQ-5D VAS、SF-36和WPAI问卷。
  • 分析时间点为第24周。

临床怎么用

  • 治疗PsA时应同时关注关节和皮肤症状的改善,以实现HRQoL的最佳提升。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Determine the contribution of joint and skin improvements to health-related quality of life (HRQoL) in patients with psoriatic arthritis (PsA). METHODS: SPIRIT-P1 and SPIRIT-P2 are phase 3 trials investigating ixekizumab, an interleukin-17A antagonist, in the treatment of patients with active PsA. Patients were randomised to ixekizumab or placebo. Outcomes included the Disease Activity Index for Psoriatic Arthritis (DAPSA), the Psoriasis Area and Severity Index (PASI), the European Quality of Life-Five Dimensions (EQ-5D) Visual Analogue Score (VAS), the 36-Item Short-Form Health Survey (SF-36) and the Work Productivity and Activity Impairment (WPAI) Questionnaire. The contribution of joint and skin improvements to HRQoL was modelled using a smoothing spline method and depicted with response surface graphics. RESULTS: In this integrated analysis, 402 patients with PsA had baseline psoriasis of ≥3% of body surface area. We applied response surface modelling to this patient data set to investigate the relationship between DAPSA, PASI and HRQoL improvements at week 24. The greatest improvement in EQ-5D VAS was associated with the largest per cent improvements in both DAPSA and PASI together, rather than DAPSA or PASI alone. Similar observations were made in domains of SF-36 and WPAI. CONCLUSION: Optimal improvements in patients' HRQoL were dependent on successful treatment of both joint and skin symptoms.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Kavanaugh A, Gottlieb A, Morita A, et al. The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies. Ann Rheum Dis. 2019. PMID: 31113794. doi:10.1136/annrheumdis-2018-215003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。